Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alkaline Water vs Chlorhexidine for Salivary S. mutans in Children
NCT06511336Phase 3Active, not recruiting
- Sponsor
- Pharos University in Alexandria
- Start
- Jul 2024
- Primary completion
- Aug 2024
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial (3 arms), sponsored by Pharos University in Alexandria. Primary endpoint: Salivary Streptococcus mutans count at 3 weeks. Started Jul 2024; status: active, not recruiting.
Beyond the preview
Go deeper on NCT06511336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06511336.